HEALTH1 week ago
Research drug for ALS could have clinical benefit, FDA officials say
Tofersen, an experimental antisense drug developed for the treatment of amyotrophic lateral sclerosis (ALS) associated with a mutation in SOD1 genes (SOD1-ALS) may have clinical benefit,...
